{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T04:21:36Z","timestamp":1741926096412,"version":"3.38.0"},"reference-count":12,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Liver Journal"],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:p> BACKGROUND: Seasonal variations in flu-like illnesses and vaccinations, vitamin D levels, alcohol intake, and sedentary lifestyles raise the possibility that seasonal variations exist in the severity of immune-mediated, alcohol, and obesity- or dyslipidemia-related chronic liver diseases, respectively. METHODS: We documented months\u2013seasons in which biochemical evidence of disease activity is greatest in adult patients with common liver disorders. Months\u2013seasons associated with peak liver enzyme levels in patients with largely immune-mediated disorders (autoimmune hepatitis, primary biliary cholangitis [PBC], and primary sclerosing cholangitis), alcoholic liver disease, and non-alcoholic fatty liver disease were documented from a hospital-based, liver diseases outpatient clinic database. RESULTS: Aside from a spike in the severity of PBC during July ( p &lt; .005), no significant associations were found between months\u2013seasons and peak liver enzyme activities in any of these liver disorders. CONCLUSIONS: These findings suggest that seasonal illnesses or immunizations and vitamin D depletion, alcohol intake, and sedentary lifestyle do not significantly exacerbate common underlying immune-mediated, alcohol, or metabolic liver disorders, respectively. <\/jats:p>","DOI":"10.3138\/canlivj.2019-0005","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T16:45:22Z","timestamp":1571157922000},"page":"184-189","source":"Crossref","is-referenced-by-count":0,"title":["Seasonal variability in the activity of common chronic liver diseases"],"prefix":"10.3138","volume":"2","author":[{"given":"Daniel","family":"Iluz-Freundlich","sequence":"first","affiliation":[{"name":"Section of Hepatology, Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Uhanova","sequence":"additional","affiliation":[{"name":"Section of Hepatology, Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald Y","family":"Minuk","sequence":"additional","affiliation":[{"name":"Section of Hepatology, Department of Medicine, and"},{"name":"Department of Pharmacology and Therapeutics, College of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1696","reference":[{"issue":"4","key":"r1","first-page":"813","volume":"24","author":"Byron D","year":"1996","journal-title":"Hepatology"},{"issue":"8","key":"r2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archinte.164.8.863","volume":"164","author":"Ockene IS","year":"2004","journal-title":"Arch Intern Med"},{"issue":"6","key":"r3","doi-asserted-by":"crossref","first-page":"A377","DOI":"10.1016\/j.autrev.2011.11.001","volume":"11","author":"Nussinovitch U","year":"2012","journal-title":"Autoimmun Rev."},{"issue":"6","key":"r4","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.24597","volume":"54","author":"McNally RJ","year":"2011","journal-title":"Hepatology"},{"key":"r5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2017.06.001","volume":"82","author":"Watad A","year":"2017","journal-title":"J Autoimmun"},{"issue":"3","key":"r6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","volume":"145","author":"Eaton JE","year":"2013","journal-title":"Gastroenterology"},{"issue":"2","key":"r7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.15288\/jsa.1993.54.157","volume":"54","author":"Lemmens PH","year":"1993","journal-title":"J Stud Alcohol"},{"issue":"3","key":"r8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/alcalc\/agx005","volume":"52","author":"Bertilsson S","year":"2017","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"r9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cld.2017.08.004","volume":"22","author":"Tsai E","year":"2018","journal-title":"Clin Liver Dis"},{"key":"r10","doi-asserted-by":"crossref","first-page":"g4596","DOI":"10.1136\/bmj.g4596","volume":"349","author":"Sattar N","year":"2014","journal-title":"BMJ"},{"key":"r11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1749-6632.2009.04759.x","volume":"1173","author":"Toplak N","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"r12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/1871528114666160105113046","volume":"14","author":"Toussirot E","year":"2015","journal-title":"Inflamm Allergy Drug Targets"}],"container-title":["Canadian Liver Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/canlivj.2019-0005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T13:25:46Z","timestamp":1741872346000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/canlivj.2019-0005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.3138\/canlivj.2019-0005"],"URL":"https:\/\/doi.org\/10.3138\/canlivj.2019-0005","relation":{},"ISSN":["2561-4444","2561-4444"],"issn-type":[{"type":"print","value":"2561-4444"},{"type":"electronic","value":"2561-4444"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}